Intellectual Property India Publishes Patent Application for 'Bispecific Antibody, Drug Conjugate Thereof, And Use Thereof' Filed by Duality Biologics (SUZHOU) Co. Ltd.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617017213 A) filed by Duality Biologics (SUZHOU) Co. Ltd., Jiangsu, China, on Feb. 16, for 'bispecific antibody, drug conjugate thereof, and use thereof.'

Inventor(s) include Zhou, Yunhua; Hua, Haiqing; Yang, Junjie; and Zhu, Zhongyuan.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "Provided are a bispecific antibody, a drug conjugate thereof, and a use thereof. The bispecific antibody comprises an EGFR binding domain and an HER3 binding domain. The provided bispecific antibody and the drug conjugate thereof have excellent endocytosis effe...